Innovation Pharmaceuticals Inc logo

Innovation Pharmaceuticals Inc

OTCPK:IPIX (USA)  
$ 0.00 -0.0059 (-58.42%) 10:08 PM EST
At Loss
P/B:
2.10
Volume:
168.63K
Avg Vol (2M):
612.29K
Volume:
168.63K
At Loss
Avg Vol (2M):
612.29K

Business Description

Innovation Pharmaceuticals Inc logo
Innovation Pharmaceuticals Inc
NAICS : 325414 SIC : 2834
ISIN : US45782D1000
Description
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 3.63
Equity-to-Asset 0.17
Debt-to-Equity 0.21
Debt-to-EBITDA -0.11
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 41.5
3-Year EPS without NRI Growth Rate 23.1
3-Year FCF Growth Rate 39.4

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 19.93
9-Day RSI 26.86
14-Day RSI 32.49
6-1 Month Momentum % 29.29
12-1 Month Momentum % -32.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.19
Quick Ratio 0.19
Cash Ratio 0.17

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.1
Shareholder Yield % 9.66

Profitability Rank

Name Current Vs Industry Vs History
ROE % -105.48
ROA % -32.58
ROIC % -37.12
ROCE % -83.45

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 2.1
EV-to-EBIT -0.6
EV-to-EBITDA -0.71
EV-to-FCF -0.76
Earnings Yield (Greenblatt) % -166.67
FCF Yield % -94.17

Financials (Next Earnings Date:2024-05-15 Est.)

IPIX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:IPIX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Innovation Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.009
Beta 1.3
Volatility % 137.6
14-Day RSI 32.49
14-Day ATR ($) 0.003996
20-Day SMA ($) 0.01292
12-1 Month Momentum % -32.98
52-Week Range ($) 0.0007 - 0.023
Shares Outstanding (Mil) 518.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Innovation Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Innovation Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Innovation Pharmaceuticals Inc Frequently Asked Questions

What is Innovation Pharmaceuticals Inc(IPIX)'s stock price today?
The current price of IPIX is $0.00. The 52 week high of IPIX is $0.02 and 52 week low is $0.00.
When is next earnings date of Innovation Pharmaceuticals Inc(IPIX)?
The next earnings date of Innovation Pharmaceuticals Inc(IPIX) is 2024-05-15 Est..
Does Innovation Pharmaceuticals Inc(IPIX) pay dividends? If so, how much?
Innovation Pharmaceuticals Inc(IPIX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1